The year 2021 in the European Heart Journal-Cardiovascular Imaging: Part I

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Ricardo Manuel Alves Monteiro Fontes De Carvalho

    Autor

Participantes de fora da FMUP

  • Edvardsen, T
  • Donal, E
  • Muraru, D
  • Gimelli, A
  • Maurer, G
  • Petersen, SE
  • Cosyns, B

Unidades de investigação

Abstract

The European Heart Journal-Cardiovascular Imaging was introduced in 2012 and has during these 10 years become one of the leading multimodality cardiovascular imaging journals. The journal is currently ranked as Number 19 among all cardiovascular journals. It has an impressive impact factor of 9.130 and our journal is well established as one of the top cardiovascular journals. The most important studies published in our Journal in 2021 will be highlighted in two reports. Part I of the review will focus on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging, while Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.

Dados da publicação

ISSN/ISSNe:
2047-2412, 2047-2404

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING  Oxford University Press

Tipo:
Article
Páginas:
1576-1583
Link para outro recurso:
www.scopus.com

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • cardiac magnetic resonance (CMR); computer tomography (CT); echocardiography; multimodality imaging; nuclear

Campos de estudo

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846

Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes

Estudo Observacional Académico (F-CHECK) . Sanofi . 2022

The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (Obesity) . 2020

Suboptimal control of cardiovascular risk factors in myocardial infarction survivors

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico (myocard) . 2020

Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2022

Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets

Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho

Estudo Clínico Académico . 2021

Citar a publicação

Partilhar a publicação